Search Within

Neil Jayendra Shah

  1. "Dermatology Service"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
  3. Editorial (1)
Groups
  1. Department of Medicine (6)
  2. Dermatology (6)
  3. Dermatology Service (6)
  4. Division of Subspecialty Medicine (6)
  5. Genitourinary Oncology Service (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Mario Lacouture (6)
  2. Andrea Moy (4)
  3. Stephanie Gu (4)
  4. David Faleck (3)
  5. Lukas Kraehenbuehl (3)
  6. Tara Maier (3)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (1)
Publications
  1. Journal of Allergy and Clinical Immunology (2)
  2. Cancers (1)
  3. Clinical Cancer Research (1)
  4. Journal of Clinical Oncology (1)
  5. Pharmaceuticals (1)
Publishers
  1. MDPI (2)
  2. Mosby Elsevier (2)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses
    Meeting Abstract

    Goleva, E.; Lacouture, M.; Lyubchenko, T.; Gu, S.; Xiao, O.; Kraehenbuehl, L.; Berdyshev, E.; Ketosugbo, K.; Moy, A.; Rotemberg, V.; more...
    Journal of Allergy and Clinical Immunology (2024)

    Fulltext@MSK | Save
  • Immunologic profiling of immune-related cutaneous adverse events with checkpoint inhibitors reveals polarized actionable pathways
    Journal Article

    Lacouture, M. E.; Goleva, E.; Shah, N.; Rotemberg, V.; Kraehenbuehl, L.; Ketosugbo, K. F.; Merghoub, T.; Maier, T.; Bang, A.; Gu, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • IL12/23 blockade with ustekinumab as a treatment for immune-related cutaneous adverse events
    Journal Article

    Gu, S. L.; Maier, T.; Moy, A. P.; Dusza, S.; Faleck, D. M.; Shah, N. J.; Lacouture, M. E.
    Pharmaceuticals (2023)

    Fulltext@MSK | Save
  • Ustekinumab for the treatment of immune related cutaneous adverse events (ircAEs)
    Meeting Abstract

    Maier, T.; Gu, S.; Shah, N. J.; Faleck, D. M.; Lacouture, M. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Dermatologic immune-related adverse events to checkpoint inhibitors in cancer
    Editorial

    Shah, N. J.; Lacouture, M. E.
    Journal of Allergy and Clinical Immunology (2023)

    Fulltext@MSK | Save
  • Contribution of the skin–gut axis to immune-related adverse events with multi-system involvement
    Journal Article

    Kuo, A. M.; Kraehenbuehl, L.; King, S.; Leung, D. Y. M.; Goleva, E.; Moy, A. P.; Lacouture, M. E.; Shah, N. J.; Faleck, D. M.
    Cancers (2022)

    Fulltext@MSK | Save